BioCentury
ARTICLE | Company News

Biovel, Ranbaxy deal

January 25, 2010 8:00 AM UTC

Ranbaxy will acquire Biovel for an undisclosed sum. Biovel develops and markets biogenerics and biopharmaceuticals, including Typhoid Vi antigen vaccine against typhoid and Hib conjugate vaccine agai...